Viscosupplementation Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Viscosupplementation Market: By Product (Single Injection, Three Injection, Five Injection), by End User (Hospitals, Orthopedic Clinics/Ambulatory Surgical Centers (ASCs), Others) and Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category: Tag:

Report

Description

Viscosupplementation Market size was valued at USD 2.2 billion in 2021 and is expected to reach a value of USD 3.4 billion by 2028, growing at a CAGR of 6.6% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Viscosupplementation Market, which has been segmented by product and end-user. By product, the viscosupplementation market has been segmented into Single Injections, Three Injections, and Five injections. The Single Injection segment is likely to be the largest and fastest-growing segment in terms of product type. Based on the end-user, the viscosupplementation is segmented into Hospitals, Orthopedic Clinics/Ambulatory Surgical Centers (ASCs), and Others. According to precision business insights, the Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In February 2020, Anika Therapeutics, Inc. acquired the Arthrosurface, a privately held manufacturer of preservation solutions and joint surfaces for active patients.

Viscosupplementation Market

MARKET SUMMARY
-
6.6%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 6.6%
  • Largest Market– North-America
  • Fastest Growing Market– Asia-Pacific

Viscosupplementation Market

  • The Viscosupplementation Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The Viscosupplementation Market is segmented based on Product, End User and geography.
Key Players
  • Sanofi
  • Anika Therapeutics, Inc.
  •  Seikagaku Corp.
  • Zimmer Biomet
  • Smith & Nephew PLC
Viscosupplementation Market Drivers

The market is likely to be driven by increasing demand for non-surgical treatments for osteoarthritis, the prevalence of lifestyle-induced problems, and developments in creating hyaluronic acid-based therapies.


Asia-Pacific Got Significant Share

Viscosupplementation Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Viscosupplementation Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Viscosupplementation Market is projected to expand at a CAGR of 6.6% during the forecast period.

The major players in the global viscosupplementation market are ​​​ Sanofi, Anika Therapeutics, Inc., Seikagaku Corp., Zimmer Biomet, Smith & Nephew PLC, Ferring Pharmaceuticals B.V., Lifecore Biomedical, LG Life Sciences Ltd., Fidia Farmaceutici S.p.A, F.Hoffmann-La Roche Ltd.

Asia-Pacific is the fastest-growing region for Viscosupplementation Market


Report

Table Of Content

1. Executive Summary
2. Global Viscosupplementation Market Introduction
2.1. Global Viscosupplementation Market – Taxonomy
2.2. Global Viscosupplementation Market –Definitions
2.2.1. By Product
2.2.2. By End User
3. Global Viscosupplementation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Viscosupplementation Market Dynamic Factors – Impact Analysis
3.6. Global Viscosupplementation Market – Competition Landscape
4. Global Viscosupplementation Market Analysis,2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Viscosupplementation Market, By Product, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
5.1. Single Injection
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Three Injection
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Five Injection
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Viscosupplementation Market Forecast, By End User, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn) (Volume, Tons)
6.1. Hospitals
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Others
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Global Viscosupplementation Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
7.1. North America
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Europe
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Latin America
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Global Viscosupplementation Market – Opportunity Analysis Index, By Product, By End User, and Region, 2022 – 2028
8. North America ViscosupplementationMarketAnalysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
8.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
8.1.1. Single Injection
8.1.2. Three Injection
8.1.3. Five Injection
8.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
8.2.1. Hospitals
8.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
8.2.3. Others
8.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
8.3.1. USA
8.3.2. Canada
8.4. North America Viscosupplementation Market – Opportunity Analysis Index, By Product, By End User, and Country, 2022 – 2028
8.5. North America Viscosupplementation Market Dynamics – Trends
9. Europe Viscosupplementation Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
9.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
9.1.1. Single Injection
9.1.2. Three Injection
9.1.3. Five Injection
9.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.2.1. Hospitals
9.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
9.2.3. Others
9.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.3.1. Germany
9.3.2. UK
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Europe Viscosupplementation Market – Opportunity Analysis Index, By Product, By End User, and Country,2022 – 2028
9.5. Europe Viscosupplementation Market Dynamics – Trends
10. Asia-Pacific Viscosupplementation Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
10.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
10.1.1. Single Injection
10.1.2. Three Injection
10.1.3. Five Injection
10.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Hospitals
10.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
10.2.3. Others
10.3. Country Analysis2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. ASEAN
10.3.5. Australia & New Zealand
10.3.6. Rest of Asia-Pacific
10.4. Asia-Pacific Viscosupplementation Market – Opportunity Analysis Index, By Product, By End User, and Country,2022 – 2028
10.5. Asia-Pacific Viscosupplementation Market Dynamics – Trends
11. Latin America Viscosupplementation Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
11.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
11.1.1. Single Injection
11.1.2. Three Injection
11.1.3. Five Injection
11.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Hospitals
11.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
11.2.3. Others
11.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Latin America Viscosupplementation Market – Opportunity Analysis Index, By Product, By End User, and Country,2022 – 2028
11.5. Latin America Viscosupplementation Market Dynamics – Trends
12. Middle East and Africa Viscosupplementation Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) (Volume, Tons)
12.1. Product Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
12.1.1. Single Injection
12.1.2. Three Injection
12.1.3. Five Injection
12.2. End User Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Hospitals
12.2.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
12.2.3. Others
12.3. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.3.1. Gulf Cooperation Council (GCC) Countries
12.3.2. Israel
12.3.3. South Africa
12.3.4. Rest of MEA
12.4. MEA Viscosupplementation Market – Opportunity Analysis Index, By Product, By End User, and Country,2022 – 2028
12.5. MEA Viscosupplementation Market Dynamics – Trends
13. Competition Landscape 
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, End User& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Allergan
13.2.2. Sanofi
13.2.3. Hoffmann-La Roche
13.2.4. Smith & Nephew Plc
13.2.5. Zimmer Biomet
13.2.6. Anika Therapeutics Inc.
13.2.7. Ferring B.V.
13.2.8. Bioventus
13.2.9. Fidia Farmaceutici S.P.A.
13.2.10. Regen Lab SA
14. Research Methodology
15. Key Assumptions and Acronyms

Report

Company Profile

  • Allergan
  • Sanofi
  • Hoffmann-La Roche
  • Smith & Nephew Plc
  • Zimmer Biomet
  • Anika Therapeutics Inc.
  • Ferring B.V.
  • Bioventus
  • Fidia Farmaceutici S.P.A.
  • Regen Lab SA

Description

Viscosupplementation Market size was valued at USD 2.2 billion in 2021 and is expected to reach a value of USD 3.4 billion by 2028, growing at a CAGR of 6.6% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Viscosupplementation Market, which has been segmented by product and end-user. By product, the viscosupplementation market has been segmented into Single Injections, Three Injections, and Five injections. The Single Injection segment is likely to be the largest and fastest-growing segment in terms of product type. Based on the end-user, the viscosupplementation is segmented into Hospitals, Orthopedic Clinics/Ambulatory Surgical Centers (ASCs), and Others. According to precision business insights, the Orthopedic Clinics/Ambulatory Surgical Centers (ASCs) segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In February 2020, Anika Therapeutics, Inc. acquired the Arthrosurface, a privately held manufacturer of preservation solutions and joint surfaces for active patients.

Reviews

There are no reviews yet.

Be the first to review “Viscosupplementation Market : Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX